Liu SV, Dziadziuszko R, Viteri S, Cappuzzo F, et al. ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors. Lung Cancer 2025;203:108516.
PMID: 40174385